Lithium Carbonate in the Treatment of Graves’ Disease with ATD-Induced Hepatic Injury or Leukopenia

Figure 1

Outcome of serum thyroid hormone concentrations. Outcome of serums FT3, FT4, and TSH concentrations in GD with hepatic injury treated with lithium are shown by black line and that in GD with leukopenia treated with lithium is shown by gray line. Difference in the outcome of serums FT3, FT4, and TSH concentrations between baseline and lithium treatment versus baseline; ; .